Use of Marrow Scintigraphy to Confirm Compensatory Marrow Rather than Active Myeloma

We present the case of a 40-year-old male with multiple myeloma for whom bone marrow scintigraphy was utilized to help differentiate between active bony myelomatous disease versus treated lesions with compensatory marrow uptake. This case demonstrates technetium (Tc-99m) sulfur colloid imaging as an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartel, Twyla B., Yarbrough, Tracy L., De Blanche, Lorraine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020796/
https://www.ncbi.nlm.nih.gov/pubmed/27651743
http://dx.doi.org/10.4103/1450-1147.172303
Descripción
Sumario:We present the case of a 40-year-old male with multiple myeloma for whom bone marrow scintigraphy was utilized to help differentiate between active bony myelomatous disease versus treated lesions with compensatory marrow uptake. This case demonstrates technetium (Tc-99m) sulfur colloid imaging as an inexpensive technique to quickly distinguish between active focal bone disease and reactive marrow.

Ejemplares similares